Leonard Weinstock, MD - Mast cell activation syndrome and potential role for LDN (2019 Conference) (LDN, low dose naltrexone)

Leonard Weinstock, MD discusses LDN  for MCAS and SIBO at the LDN 2019 Conference. He discusses the etiology, symptoms, testing, and therapy for MCAS, SIBO, and POTS; and presents related cases.
 

Kent Holtorf, MD - LDN should be considered a first-line therapy for CFS/FM (2019 Conference) (LDN, low dose naltrexone)

Kent Holtorf, MD - Causes of Hashimoto's (2019 Conference) (LDN, low dose naltrexone)

Kent Holtorf, MD discusses Hasimoto’s thyroiditis at the LDN 2019 Conference. He discusses the mechanisms of thyroid dysfunction, causes and evaluation of Hashimoto’s thyroiditis, Hashimoto’s in obesity, and treatments of Hasimoto's
 

Ginevra Liptan, MD - Turning down the volume on fibromyalgia pain (2019 Conference) (LDN, low dose naltrexone)

Ginevra Liptan, MD discusses fibromyalgia, including its symptoms, the CNS sensitization in fibromyalgia, how LDN can lessen fibromyalgia pain, and ways to avoid interactions between opiate-based pain medications and LDN. Case studies.

Last week, I did something I thought I’d never do again.  I backpacked!  

Fibromyalgia Walls Closing In

Andrew David Shiller, MD - Is LDN a magic bullet for Fibromyalgia and Chronic Illness? (2019 Conference) (LDN, low dose naltrexone)

Amy Lamb, Pharm - A Pharmacist's Perspective on Comprehensive Immune Health Consultations and Applications of LDN (2019 Conference) (LDN, low dose naltrexone)

FDA Grants Orphan Drug Status to Soin Therapeutics for Low Dose Naltrexone (LDN) to Treat Complex Regional Pain Syndrome (CRPS) (News)

Marty - US: Restless Leg Syndrome (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Marty from the US takes low dose naltrexone (LDN) for Restless Leg Syndrome.(RLS)

Dr John Kim, LDN Radio Show 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: Today I'm joined by Dr. John Kim from Georgia Integrative Medicine Clinic in the US. Thank you for joining us today.